Retatrutide: A Triple Agonist Showing Potent Anti-Cancer Effects in Obesity Models

Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression. Authors: Marathe SJ, Grey EW, Bohm MS, Joseph SC, Ramesh AV, Cottam MA, Idrees K, Wellen KE, Hasty AH, Rathmell JC Journal: npj metabolic hea…